IGC Pharma (IGC) Change in Receivables (2010 - 2025)
IGC Pharma's (IGC) quarterly Change in Receivables came in at -$44000.0 in Q3 2025, down 375.0% year-over-year from $16000.0 in Q3 2024, and down 183.02% quarter-over-quarter from $53000.0 in Q2 2025.
Powered by 
Analysis
IGC Pharma (IGC) Change in Receivables (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Change in Receivables for 16 consecutive years, with -$44000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Change in Receivables fell 375.0% year-over-year to -$44000.0 in Q3 2025; TTM through Sep 2025 was $12000.0, a N/A change from a year earlier, with the FY2026 full-year figure at $24000.0, up 200.0% from the prior year.
- Change in Receivables was -$44000.0 for Q3 2025 at IGC Pharma, down from $53000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $118000.0 in Q2 2023 and troughed at -$132000.0 in Q1 2023.
- A 5-year average of -$3368.4 and a median of -$2000.0 in 2025 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 581.82% in 2025, down 375.0% in 2025.
- Over 5 years, Change in Receivables stood at $25000.0 in 2021, then soared by 148.0% to $62000.0 in 2022, then tumbled by 170.97% to -$44000.0 in 2023, then soared by 111.36% to $5000.0 in 2024, then tumbled by 980.0% to -$44000.0 in 2025.
- The last three Change in Receivables figures came in at -$44000.0 (Q3 2025), $53000.0 (Q2 2025), and -$2000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 1.09 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 333.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 140.20 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 838.50 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -53.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 31.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 269.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | IGC Pharma | 27.77 Mn | 27.51 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -44,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 16,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Dec 31, 2023 | -44,000.00 |
| Sep 30, 2023 | -88,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | -132,000.00 |
| Dec 31, 2022 | 62,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | -39,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -13,000.00 |
| Mar 31, 2021 | -51,000.00 |
| Dec 31, 2020 | -41,000.00 |